Medical Device & Technology

Imperative Care's Symphony Thrombectomy System gains FDA clearance, advancing pulmonary embolism treatment with enhanced control and faster recovery options.

Biedermann Medtech transforms its U.S. strategy, focusing on licensing and integrated services for spinal and extremity surgery technologies.

A federal judge's ruling empowers hospitals by ensuring access to affordable, reprocessed cardiac catheters, challenging Johnson & Johnson's market dominance.

The device is designed to both prevent and treat the neurodegenerative condition, which affects more than 6.5 million Americans and 50 million people worldwide

The partnership aims to improve early detection and management of CKD in high-risk and underserved populations by integrating Carna Health’s digital platform with Siemens Healthineers’ global diagnostics infrastructure.

Glucose biosensor combined with artificial intelligence-powered platform provides real-time insights into how food, exercise, stress, and sleep affect the body.

The partnership will combine Vyome’s health care industry expertise and resources with Embryyo’s medical technology capabilities, with the goal of advancing smart medical devices that could reshape disease management and treatment.

Pilots at Mass General Brigham and Emory Healthcare show significant reductions in documentation burnout.

Nalu Medical unveils a compact wearable device for chronic pain therapy, enhancing comfort and expanding treatment options for patients with peripheral nerve stimulation.

AI adoption and collaboration trends in the medical device industry

67 health organizations sign letter urging faster access and coverage

FTC challenge could potentially impact heart valve innovation and patient access in the TAVR market.

New randomized trial suggests wearable devices may support resilience and lower burnout odds among physicians.

New platform aims to speed approvals, cut denials and ease physician workload.

Masimo's O3 Regional Oximetry gains FDA clearance, enhancing tissue oxygen monitoring for improved patient care in critical settings.

Cohesys pioneers drill-free fracture repair with BoneTape, offering a patient-friendly alternative for craniofacial injuries and enhancing recovery experiences.

Philips invests over $150 million in U.S. medtech manufacturing, expanding facilities and creating jobs to enhance AI-driven health care solutions.

The acquisitions give StatLab, a developer and manufacturer of medical diagnostic supplies and equipment, a direct foothold in France, Germany, Italy and the United Kingdom.

ArteraAI Prostate advances prostate cancer care with FDA authorization, offering AI-driven insights for personalized treatment and improved diagnostic efficiency.

Cardiosense appoints John Martin as CMO, enhancing AI-driven cardiac care and advancing regulatory efforts for innovative hemodynamic monitoring solutions.

SetPoint Medical secures $140 million to launch innovative neuroimmune modulation therapy for rheumatoid arthritis, advancing treatment for autoimmune diseases.

Discover how Orpyx's innovative sensory insoles advance diabetes foot care, enhancing health outcomes and reducing costs through real-time monitoring and support.

Apreo Health pioneers emphysema treatment with innovative device trials, aiming to transform care for millions suffering from COPD.

Ventric Health advances heart failure detection with the Vivio System, enabling accurate diagnoses in primary care for improved heart health outcomes.

TAO Digital enhances its medtech expertise by acquiring DigitalSoftMinds, boosting capabilities in medical devices and AI-powered solutions for regulated industries.

Yale begins enrolling patients in PRIME study using next-generation Swoop system

Rowan University and NJEDA launch a Strategic Innovation Center to boost medical device investments and accelerate medtech innovation in South Jersey.

Cardiosense's CardioTag gains FDA clearance, advancing cardiac monitoring with wearable technology for personalized, noninvasive heart health insights.

CMS establishes a national payment for AI ECG analysis, paving the way for enhanced cardiovascular diagnostics and early patient intervention.